chlortetracycline and Bronchitis

Seven-day courses of either pivmecillinam 200 mg plus pivampicillin 250 mg (Miraxid) or a combination of tetracycline hydrochloride, chlortetracycline hydrochloride and demeclocycline hydrochloride (Deteclo) 300 mg, both given twice daily, were compared in a multicentre general practice study in 408 patients with symptoms of upper or lower respiratory tract infection. Patients were stratified into four diagnostic groups: sinusitis, otitis media, throat infections, and acute bronchitis and randomly allocated to treatment within these groups. Assessment at 7 days showed no difference in clinical efficacy between the two treatments where 193 of the 208 infections receiving Miraxid (93%) were rated as either cured or improved compared with 181 of the 201 infections treated with Deteclo (90%). At 7 days, the percentage of patients completely free of symptoms was the same for both groups (66%). The mean time for symptoms to clear was 3.9 days in the Miraxid group and 4.0 days in the Deteclo group. Side-effects were reported by significantly fewer patients in the Miraxid group (9.3%) than the Deteclo group (17.5%) (p less than 0.05) and six patients in the latter group failed to complete the course of treatment. Miraxid given twice daily for respiratory tract infections is as effective as Deteclo but causes significantly fewer side-effects.

Topics: Adolescent; Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Ampicillin; Bronchitis; Child; Chlortetracycline; Demeclocycline; Drug Combinations; Family Practice; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngeal Diseases; Pivampicillin; Respiratory Tract Infections; Sinusitis; Tetracycline

Topics: Acute Disease; Adult; Aged; Bronchitis; Chlortetracycline; Cholecystitis; Chronic Disease; Cystitis; Demeclocycline; Female; Humans; Male; Middle Aged; Pyelitis; Tablets; Tetracycline; Tuberculosis, Pulmonary; Vibrio Infections

Topics: Acute Disease; Bronchitis; Bronchopneumonia; Chlortetracycline; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Respiratory Tract Infections

Topics: Bronchitis; Bronchopneumonia; Chlortetracycline; Humans; Pyelitis

Topics: Anti-Bacterial Agents; Antitubercular Agents; Asthma; Bronchiectasis; Bronchitis; Chloramphenicol; Chlortetracycline; Chymotrypsin; Empyema; Humans; Hydrocortisone; Kanamycin; Oxytetracycline; Penicillins; Peptide Hydrolases; Pleurisy; Pneumonia; Pulmonary Emphysema; Respiratory System; Respiratory Tract Diseases; Tuberculosis; Tuberculosis, Pulmonary

Topics: Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Chlortetracycline; Demeclocycline; Drug Therapy; Haemophilus influenzae; Humans; Penicillin V; Penicillins; Pneumococcal Infections; Sputum

Topics: Asthma; Biomedical Research; Bronchitis; Bronchopneumonia; Child; Chlortetracycline; Double-Blind Method; Drug Therapy; Escherichia coli; Haemophilus influenzae; Humans; Nasopharynx; Oxytetracycline; Pneumonia; Preventive Medicine; Proteus; Pseudomonas; Radiography, Thoracic; Staphylococcus; Streptococcus pneumoniae; Toxicology

Topics: Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Chlortetracycline; Drug Therapy; Protein Synthesis Inhibitors; Tetracycline; Toxicology

Topics: Adolescent; Biomedical Research; Bronchitis; Child; Chlortetracycline; Double-Blind Method; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Humans; Infant; Nasal Mucosa; Placebos; Pneumonia; Preventive Medicine; Toxicology

Topics: Anti-Bacterial Agents; Bronchitis; Chlortetracycline; Humans; Respiratory System; Respiratory Tract Infections; Tetracycline

Topics: Bronchitis; Chlortetracycline; Hospitals, General; Hospitals, Urban; Penicillins

Topics: Bronchiolitis; Bronchitis; Chlortetracycline; Humans; Infant